TABLE 1.
Characteristic | Colon (n = 204) | Rectum (n = 13) | p |
---|---|---|---|
Gender | 0.15 | ||
Female | 92 (45.1 %) | 3 (23.1 %) | |
Male | 112 (54.9 %) | 10 (76.9 %) | |
Age (year) mean (SD) | 53.2 (12.9 %) | 48.8 (11.1 %) | 0.18 |
ECOG | 0.70 | ||
0/1 | 169 (82.8 %) | 12 (92.3 %) | |
2+ | 32 (15.7 %) | 1 (7.7 %) | |
R status | 1.00 | ||
R0/1 | 103 (50.5 %) | 7 (53.8 %) | |
R2 | 101 (49.5 %) | 6 (46.2 %) | |
Readmit | 1.00 | ||
No | 157 (77.0 %) | 10 (76.9 %) | |
Yes | 47 (23.0 %) | 3 (23.1 %) | |
Prior surgical score | 0.009 | ||
0 | 15 (7.4 %) | 5 (38.5 %) | |
1 | 78 (38.2 %) | 3 (23.1 %) | |
2+ | 93 (45.6 %) | 5 (38.5 %) | |
Node status | 1.00 | ||
Positive | 134 (66.7 %) | 8 (66.7 %) | |
Negative | 67 (33.3 %) | 4 (33.3 %) | |
Albumin (g/dl), mean (range) | 3.7 (2.0–4.9) | 3.8 (1.6–4.8) | 0.60 |
Complications | 0.57 | ||
No | 87 (42.6 %) | 7 (53.8 %) | |
Yes | 117 (57.4 %) | 6 (46.2 %) | |
30-day mortality | – | ||
No | 193 (94.6 %) | 13 (100.0 %) | |
Yes | 11 (5.4 %) | 0 (0.0 %) | |
Long-term mortality | – | ||
No | 47 (23.0 %) | 6 (46.2 %) | |
Yes | 157 (77.0 %) | 7 (53.8 %) | |
Median follow-up (months) | 88.1 | 40.1 | 0.01 |
Median survival (months) | 17.3 | 14.6 | – |
ECOG Eastern Cooperative Oncology Group
Data are presented as n (%) unless otherwise indicated